Chemical synthesis of 3PA, 3PB and 3PC
Conversion 1 + 2  3 (Scheme 1)
A solution of 100 mL (d 1.015 g/mL) of BOC anhydride (100.86 gr di-tert-butyldicarbonate 2) in CHCl 3 was added in 2 h to a solution of the diethanamine 1 (7.5 gr) in CHCl 3 (343ml) maintaining a temperature in the range of 0-5 0 C; the final solution (443 mL) was allowed to warm to 15-18 0 C and kept overnight at the same temperature. The crude reaction was then washed with a saturated solution of NaHCO 3 (2x300 mL) and with saturated brine (2x300 mL), the organic phase was dried on MgSO 4 , evaporated in vacuo at 40 0 C to provide 6.9 g of pure mono-NBOC derivative 3 (80.6% yield).
NMR of 3 (CDCl 3 ) : 5.21 (brs, -NHCO , 1H), 3.62 (s, -OCH 2 CH 2 O-, 4H), 3.55 (brt, 5.2 Hz, -OCH 2 CH 2 NHCO, 2H), 3.52 (t, 5.1 Hz, -OCH 2 CH 2 NH 2 , 2H), 3.32 (q, , 5.2 Hz, -CH 2 -NHCO, 2H), 2.88 (t, 5.2Hz, -CH 2 -NH 2 , 2H), 1.44 (s, (Me) 3 -BOC, 9H).
Conversion 3 + 4  5 (Scheme 1)
A solution of equimolar amount of amine 3 (1.938 g) and 3-(prop-2-ynyloxy)propanoic acid 4 (1.00 g), in acetonitrile (40 mL) and DMAP (2 equivalent) followed by addition of EDC (1 equivalent) was stirred at 19-21 0 C overnight, after which it was evaporated in vacuo at 40 0 C, stirred in ether (50mL) and re-acidified to pH 1 with 2M HCl (aq). Then the solution was extracted with EtOAc (50mL), DCM (2x 50mL), EtOAc (50mL). The organic extracts were combined, washed with sat NaHCO 3 , dried (MgSO4) and evaporated in vacuum at 40 0 C to provide 5 (oil, 2.00 g, yield 71.5%) NMR of 5 (CDCl 3 ): δ 6.40 (brs , NHCO, 1H), 5.03 (brs, NHCO, 1H), δ 4.17 (d, 2.4 Hz, -OCH 2 -alkyne, 2H), 3.81 (t, 6.0 Hz, alkyneCH 2 -OCH 2 -, 2H), ), 3.61 (s, -OCH 2 CH 2 O-, 4H), 3.55 (q, 5.2 Hz, -OCH 2 CH 2 NHCOOBoc, 2H), 3.48 (t, 5.1 Hz, -OCH 2 CH 2 NHCO, 2H), 3.32 (q, 5.2 Hz, -CH 2 -NHCO, 2H), 2.50 (t, 5.5Hz, -CH 2 -CONH, 2H), 2.45 (t, 2.4 Hz, alkyne-H, 1H), 1.44 (s, (Me) 3 -BOC, 9H).
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Conversion 5  6 (Scheme 1)
A stirred a solution of 5 (2 g) in dichloromethane (40 mL) was added TFA (10 molar equivalents) and kept at 20-22 0 C for 3 h. After addition of 100 mL CHCl 3 the solution was evaporated in vacuo leading to a yellow oil which was further purified by stirring with K 2 CO 3 (aq) (10g/10ml) and EtOAc (20ml) and finally extracted. Combined organic phases were dried (MgSO 4 ), filtered and evaporated at 40 0 C in vacuo to a viscous yellow oil. This crude material was further purified by using column Silica gel (35 g) chromatography by using dichloromethane/methanol/ammonium hydroxide gradient elution. Clean product was collected in fraction 3-7 affording a pale yellow oil still containing 1 eq of ammonium trifluoroacetate which was removed after final washing of its AcOEt solution with NH 4 OH (aq) saturated with NaCl followed by extraction with EtOAc and THF. Combined organic phases, dried (MgSO 4 ) and evaporated at 40 0 C in vacuo provides 6 a clear oil ( Conversion 6  7 + 8  10 (Scheme 1 and Scheme 2)
1.206 grams of amine 6 was treated dropwise at r.t. (22 0 C) for 2 h under stirring with an equimolar amount of CDI (0.757 g) in pyridine (15 mL) under N 2 and kept under stirring at r.t. overnight.
LCMS of the crude reaction showed, besides the expected product 7, also formation of the product 8 due to internal cyclization of 7 itself. Puromycin was then added at different interval (overall added amount 2.546 g) keeping the bath at 100 0 C for 7 h and left overnight a with stirring at r.t.. The crude was evaporated in vacuo at 50 0 C affording a brown oil which was extracted by using different mixture of AcOEt/water and DCM/water partitioning system. The organic phase was purified by silica gel column chromatography (43 g) by using DCM/MeOH gradient elution obtaining at the end fractions containing almost pure 10 To a pyridine solution (7 mL) of puromycin derivative 10 (720 mg, 1 molar equivalent) stirred at r.t. under N 2 were added dropwise in 30 minutes 0.2 mL in DCM of diazirine 13 (155 mg, 1 molar equivalent) and the solution was kept at 0-5 C; after 2 further addition of 13 (2 molar equivalent) in 2 h, the reaction was quenched by addition of 10 mL of distilled water and 10 mL of AcOEt; organic phase obtained after extraction were dried over MgSO 4 , evaporated in vacuo at 40 C to give a raw reaction products as an oil. The latter was then purified by Silica gel column chromatography (35g) by using EtOAc/MeOH gradient elution collecting 120 fractions of 25mL. By LC-MS and NMR analysis, fractions 13-30 contained almost pure the bis-aziridino derivative 16 (301mg, 3PC, purity 95%), fractions 57-90 the mono-aziridino derivative 15 (52 mg, 3PB, purity 96% ) and finally 70.6 (d, CH-purom), 70.5(t), 70.1 (t), 69.8(t), 66.1 (t, CH-purom),63.9 (t, CH-purom), 62.2 (t) , 58.3 (t) , 55.7 (q), 55.2 (d, CH-purom), 50.4 (d, CH-purom), 40.1 (t), 39.5 (t) , 37.8 (t), 36.7 (t) , 33.5 (t), 19.7 (q). 
LC/MS of of 3PB
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Pipeline MS-data analysis. Raw files from gel bands were analyzed using Proteome Discoverer 2.2 (Thermo Fisher) against UniProt/SwissProt human and bovine database (2017_01, 26169 protein entries) as the cells were cultured with bovine serum, using Mascot 2.6.0. The mass tolerance was set at 10 ppm for the precursor ions and at 20mmu for fragment ions. Carboxyamidomethylation of cysteine was used as a fixed modification and oxidation of methionine as variable modifications. Two missed cleavages were allowed. The precursor peak area was used for protein quantification. Raw files from beads were analyzed using Proteome Discoverer 2.2 (Thermo Fisher) against UniProt/SwissProt human database (2017_01, 20171 protein entries) using Mascot 2.6.0. The mass tolerance was set at 10 ppm for the precursor ions and at 0.8 Da for fragment ions. Carboxyamidomethylation of cysteine was used as a fixed modification and oxidation of methionine as variable modifications. Two missed cleavages were allowed. The precursor peak area was used for protein quantification. For in-column digestion data: all the gene having at list a signal in one of the four replicates were included in the analysis.
For in-gel digestion data: we removed all the proteins that were not detected in the input and we kept all genes having at list a signal in one of the four replicates. For in-beads digestion data: to account for low abundant protein we set a value of 25998.91992 (minimal detected value in all samples) for all the protein not detected in 3PB-beads or PEG-beads samples. Since we used two different types of commercial beads for pull-down (Magar -Immagina Biotech cat-no016-00-007-2-1 and Sepharose -GE healthcare cat. no 28985799), we calculate the ratio of (D1) 3PB Magar-beads/ (E2) PEG magar beads and (D2) 3PB sepharose beads / (E2) PEG sepharose beads.
All the proteins with a mean FC enrichment ≥ 1.3 or ≥ 2.5.
Cy3 cell labeling. MCF7 cells were grown to 80% of confluence and treated with cycloheximide (CHX, 10 µg/mL, 5 min, 37 °C) and the 3PC/3PB probe (10 min, 37 °C). For Torin 2 and pp242 treatment, MCF7 cells were incubated with pp242 (250 nM) and Torin 2 (500 nM) at 37 °C for 60 min before adding CHX. After that, cells were washed thrice with cold PBS (containing CHX 10 µg/mL), placed on ice and irradiated under a UV lamp at 365 nm for 5 min (0.75 J/cm2) followed by washing twice with PBS. Subsequently, cells were fixed and permeabilized with ice cold 100% methanol for 5 min at -20 °C. Post permeabilization, cells were washed twice with PBS and incubated with 1 ml "click" buffer (PBS containing 2.5 µM picolyl-azide Cy3, 0.1 mM Cu ++ , 0.5 mM THPTA and 5 mM ascorbic acid) for 1 hour at room temperature. Cells were blocked with blocking buffer (5% BSA, 0.3% triton x 100 in PBS) for 1 S12 hour and incubated with (i) the indicated primary antibody (1:200) and then with (ii) the secondary antibody (1:300) in 3% BSA, 0.2% saponin, 2.5% vol/vol polyvinyl sulfonic acid.
Finally, cells were washed twice in PBS with a final overnight washing at +4°C in PBS + 0.1% tx100. The day after the slides where washed thrice with PBS, mounted with ProLong Gold Antifade (Invitrogen, Catalog no P36962) and viewed using a confocal microscope.
Confocal Microscopy. Laser scanning confocal microscopy (LSCM) analysis was carried out using a Leica DM6000CD microscope equipped with an argon laser source. MCF7 cells were immunostained with RPL26, calnexin or HSC-70 FITC (Ex 492 nm, Em.: 519 nm) and 3PB/3PC-Cy3 (Ex. 552 nm, Em 578 nm).
3Px pull-down assays of ribosome complex. After PP242 (250 nM, for 1h ) and Torin2 (500 nM for 1h) treatment, MCF-7 cells were incubated with cycloheximide (CHX, 10 µg/mL, 5 min, 37 °C) and 3PB (10 min, 37 °C), then, placed on ice and irradiated under a UV lamp at 365 nm for 5 min (0.75 J/cm2). Cells were harvested with hypotonic cytoplasmic lysis buffer and lysates (0.3 mL) were incubated with picolyl-PEG4-biotin (1,6 mM), CuSO4 (80 µM), THPTA (400 µM) and sodium ascorbate (4 mM), on a wheel for 1h at 4 °C. After click reaction, the cell lysates were incubated with 100 µL of Dynabeads MyOne™ Streptavidin C1 (ThermoFisher), on a wheel for 30 min at 4 °C. 
Immunoblotting. List of antibodies used:
